BioSpace News Archive

Science and Medicine Group Inc. today announced the appointments of Leo O’Connor as Editor in Chief of LabPulse, and Greg Slabodkin as Editor in Chief of The Science Advisory Board.

The American Board of Oral and Maxillofacial Surgery named new leaders during their September 2022 Annual Meeting in New Orleans.

Virinx LLC (“VIRINX” or “the Company”), a developer of highly integrated IoT devices, announced the successful preliminary test results of its Viper22 system, which is a miniature noncontact wound and fungus infection treatment system.

Zymeworks Inc. today announced that management will report its third quarter 2022 financial results after market close on November 8th , 2022.

The National Kidney Foundation is pleased to announce the appointment of Anne Motsenbocker to its national Board of Directors.

BioSkryb Genomics, a pioneer in developing scientifically advanced single-cell analysis molecular tools, announced a multi-year agreement with Cooper Genomics, a leader in the reproductive health market, to license BioSkryb’s proprietary genomic amplification technology.

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “TELO”) is pleased to announce that it has recently engaged Richard A. Bender MD, FACP, a veteran multiple myeloma (“MM”) clinician, key opinion leader and medical diagnostics expert to establish and chair TELO’s MM clinical advisory board (the “Advisory Board”).

SOHM, Inc., a generic pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces that it has signed a memorandum of understanding with SRAM & MRAM Group for injections of required funds for the Company’s various new pipeline projects.

Promatix, a London-based oncology drug discovery and development company that uses multi-omics to identify novel therapeutics, today announced a collaboration with the laboratory of Professor Jasmin Fisher to develop new proprietary computational executable cancer models for Promatix’s CipherPro suite of algorithms to mine the TxPro databank and identify new oncology drug targets.

Evozyne named Zach Serber as its chief operating officer, a newly created position charged with directing scientific operations for the fast-growing biology engineering company.